Acadian Asset Management »

Context Therapeutics shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $559k 1.0M 0.55
2024-12-31 $17k 17k 1.02

More positions owned by Acadian Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Bk Nova Cad (BNS)
Applied Materials (AMAT)
Micron Technology (MU)
Cibc Cad (CM)
Meta Platforms Cl A (META)
Costco Wholesale Corporation (COST)
Broadcom Ord Shs (AVGO)
Kla Corp Com New (KLAC)
Alphabet Cap Stk Cl C (GOOG)
Asml Hldg Nv N Y Registry Shs (ASML)

View all positions for Acadian Asset Management

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics